A 62-Year-Old Causcasian Man With Chronic Myelogenous Leukemia in Cytogenetic Relapse

Learn to interpret clinical data reviewing the implications of genetic mutations in refractory CML, and the potential activity of subsequent treatment selections.
Duration
August 25, 2009 until August 24, 2010
Credits
Maximum of 2.0 AMA PRA Category 1 Credits™
Faculty
Moshe Talpaz, MD | Carol Ann Huff, MD

This course is not part of OncologySTAT.
By clicking the button below you will be leaving this website.


Community CommentsTotal comments to date:

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration